摘要
目的探讨1例ABO血型系统A变异型的分子遗传学背景。方法采用血清学方法鉴定ABO血型,测定血浆α-1,3-N-乙酰半乳糖胺转移酶的活性,用PCR扩增AB0基因的7个外显子及启动子序列,测序分析第7外显子单倍体。结果先证者红细胞ABO血型为A弱表现型,AB0基因全编码区测序发现8处核苷酸杂合位点,分别为第6外显子的261delG缺失和297A/G、第7外显子的421c/T、467C/T、646T/A、681G/A、771C/T以及829G/A杂合变异。单链测序分析提示,其中1条为002等位基因,另一个等位基因除421T〉C和467C〉T突变外,其他变异位点与A101等位基因一致。421T〉C突变可导致A糖基转移酶第141位丝氨酸替换为脯氨酸(Serl41Pro)。结论产生弱A表型的原因可能是由于A糖基转移酶基因421T〉C突变引起编码的氨基酸改变,使α-1,3-N乙酰半乳糖胺转移酶活性减弱,导致A抗原弱表达。
Objective To investigate the molecular basis of an individual featuring weak A phenotype of ABO blood group system. Methods Serologic investigations, serum transferases activity assay and absorption elution test were carried out to identify the ABO blood group. The 7 exons and flanking introns of ABO glycosyltransferase gene were amplified with polymerase chain reaction (PCR). The products were sequenced bidirectinally following enzyme digestion. Haplotypes of exons 6 and 7 of the ABO gene were analyzed. Results A weak A antigen was identified on red blood cells of the proband. Eight heterozygous sites in exons 6 and 7 (261delG 297A/G, 421C/T, 467C/T, 646T/A, 681G/A, 771C/T, 829G/A) of the ABO gene were identified. Based on haplotype analysis, one allele was determined as 002, while a novel mutation 421T〉C was identified in another allele, which resulted in the amino acid change Ser141Pro of the A glycosyltransferase. Conclusion Above results suggested that amino acid substitutions resulted from a novel mutation 421T〉C of the ABO gene may decrease the enzymatic activity and result in the weak A phenotype.
出处
《中华医学遗传学杂志》
CAS
CSCD
北大核心
2015年第1期105-108,共4页
Chinese Journal of Medical Genetics